Form 4: Enfusion CFO Bradley Herring Reports Disposal of Shares Following Merger with Clearwater Analytics

Sentiment:

SEC Form 4


Bradley Herring, CFO of Enfusion, Inc., reports the disposal of all Enfusion securities following the completion of a merger with Clearwater Analytics Holdings, Inc.

Summary

  • Bradley Herring, the Chief Financial Officer of Enfusion, Inc., filed a Form 4 to report changes in beneficial ownership of Enfusion securities.
  • The filing indicates that Mr. Herring disposed of shares of Class A Common Stock due to the merger agreement between Enfusion and Clearwater Analytics Holdings, Inc.
  • Under the merger agreement, each eligible share of Enfusion's Class A common stock was converted into the right to receive cash, shares of Clearwater Analytics Class A common stock, or a combination thereof.
  • As a result of the merger, Mr. Herring ceased to be the beneficial owner of any securities of Enfusion, marking this Form 4 as an exit filing.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it primarily reports the completion of a merger and the resulting disposal of shares by an executive. The merger itself could be viewed positively or negatively depending on individual shareholder perspectives.

Positives

  • The merger provides liquidity to Enfusion shareholders, allowing them to realize value for their shares.
  • Shareholders had the option to choose between cash, stock, or a combination thereof, providing flexibility in the merger consideration.

Negatives

  • As a result of the merger, Bradley Herring no longer holds any securities in Enfusion, indicating a complete exit.

Future Outlook

The document does not contain specific forward-looking statements for Enfusion, as it focuses on the completion of the merger.

Industry Context

The merger between Enfusion and Clearwater Analytics reflects a trend of consolidation in the financial technology sector, where companies seek to expand their capabilities and market reach through strategic acquisitions.

Stakeholder Impact

  • Shareholders of Enfusion have been impacted by the merger, receiving cash, Clearwater Analytics shares, or a combination thereof.
  • Enfusion's employees may experience changes as a result of the integration with Clearwater Analytics.

Key Dates

DateDescription
01/10/2025Date of the Agreement and Plan of Merger between Enfusion and Clearwater Analytics Holdings, Inc.
04/21/2025Date of the transaction (disposal of shares) and filing of the Form 4.

Keywords

Merger, Enfusion, Clearwater Analytics, Form 4, Beneficial Ownership, Securities, CFO, Bradley Herring

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.